SCHEMBL23735916

SCHEMBL23735916

Cc1ccccc1C(C)C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.46
ACHE P22303 2/20 0.39
TSHR P16473 1/20 0.39
ACP3 P15309 1/20 0.36
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34
SLC6A3 Q01959 2/20 0.34
GAA P10253 1/20 0.34
ADRA2A P08913 2/20 0.34
ADRA2B P18089 2/20 0.34
ADRA2C P18825 1/20 0.34
GABRA1 P14867 1/20 0.33
GABRB2 P47870 1/20 0.33
P2RX7 Q99572 1/20 0.32
ALDH1A1 P00352 2/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA7 P43166 1/20 0.32
CA9 Q16790 1/20 0.32
ADRB2 P07550 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20326529 0.79 GABRA1 (0.44) TSHRSLC6A2GABRA1GABRB2P2RX7
SCHEMBL16233655 0.77 HSD11B1 (0.39) ACHEGAAGABRA1GABRB2ALDH1A1
SCHEMBL18262837 0.76 GABRA1 (0.58) ESR1TSHRSLC6A2GAAADRA2A
SCHEMBL19196670 0.76 ADRB2 (0.42) TSHRACP3SLC6A2SLC6A4SLC6A3
SCHEMBL25214138 0.76 ESR1 (0.45) ESR1ACHETSHRACP3SLC6A2
SCHEMBL12037328 0.76 ESR1 (0.45) ESR1ACHETSHRACP3SLC6A2
SCHEMBL10150476 0.76 ESR1 (0.45) ESR1ACHETSHRACP3SLC6A2
SCHEMBL28688991 0.76 ESR1 (0.45) ESR1ACHETSHRACP3SLC6A2
SCHEMBL17297902 0.73 ESR1 (0.52) ESR1ACHETSHRACP3SLC6A2
SCHEMBL13405964 0.73 GABRA1 (0.56) ESR1TSHRSLC6A2GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3790886-B1 KRAS G12C INHIBITORS FOR THE TREATMENT OF CANCER AMGEN INC (US) 2024-06-26 EP disclosed
EP-3558955-B1 BENZISOTHIAZOLE, ISOTHIAZOLO[3,4-B]PYRIDINE, QUINAZOLINE, PHTHALAZINE, PYRIDO[2,3-D]PYRIDAZINE AND PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS FOR TREATING LUNG, PANCREATIC OR COLORECTAL CANCER AMGEN INC (US) 2021-08-11 EP disclosed